T0	Outcomes 456 457	.
T1	Outcomes 458 478	The overall survival
T2	Outcomes 557 612	significant increase in the duration of first remission
T3	Outcomes 684 706	first relapse to death
T4	Outcomes 780 823	the incidence of first or second remissions
T5	Outcomes 829 862	the time taken to enter remission
T6	Outcomes 1048 1065	longer remissions
T7	Outcomes 1096 1156	developed leukaemic central-nervous-system (CSN) involvement
T8	Outcomes 1251 1270	in remission length
T9	Outcomes 1306 1335	in survival after CNS relapse
T10	Outcomes 1465 1515	may protect the CNS against leukaemic infiltration
T11	Outcomes 1564 1582	of CNS prophylaxis